Growth Direct System Workshop - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Growth Direct™ System Workshop

During this event, attendees will interact with the Growth Direct™ System and applications including sterility, environmental monitoring, water and bioburden testing. Representatives of Rapid Micro Biosystems will discuss technical data, difficult to handle samples, and will review the validation approach. The event includes a live demonstration of the Growth Direct System.



The Growth Direct™ System uses proprietary digital imaging technology that automatically enumerates microcolonies days earlier than the traditional visual plate counting methods. The system captures the native fluorescence (autofluorescence) that is emitted by all living cells. By detecting microcolonies composed of a small number of cells, the Growth Direct test can start to detection microbial growth in a matter of hours with final results in half the time of the traditional, visual methods. Because the test is non-destructive, colonies are available for identification without the need for a re-culture step.

To register for the 17 October event, click on the registration link: www.SwiftPage2.com/survey/2013Oct17EUWorkshop

Contact Details:
www.rapidmicrobio.com
info@rapidmicrobio.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
FindPharma Custom Search

Click here